SEARCH

SEARCH BY CITATION

References

  • 1
    Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002; 359: 10118.
  • 2
    Stupp R, Hegi ME, Mason WP et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10: 45966.
  • 3
    Kleihues P, Louis DN, Wiestler OD et al. WHO grading of tumours of the central nervous system. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. World Health Organization Classification of Tumours of the Nervous System. Lyon, France: IARC Press, 2007; 1011.
  • 4
    van de Vijver MJ, He YD, van't Veer LJ et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 19992009.
  • 5
    Godard S, Getz G, Delorenzi M et al. Classification of human astrocyticgliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Cancer Res 2003; 63: 661325.
  • 6
    Nutt CL, Mani DR, Betensky RA et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 2003; 63: 16027.
  • 7
    Sorlie T, Tibshirani R, Parker J et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003; 100: 841823.
  • 8
    Freije WA, Castro-Vargas FE, Fang Z et al. Gene expression profiling of gliomas strongly predicts survival. Cancer Res 2004; 64: 650310.
  • 9
    Rich JN, Hans C, Jones B et al. Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res 2005; 65: 40518.
  • 10
    Phillips HS, Kharbanda S, Chen R et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006; 9: 15773.
  • 11
    Yamanaka R, Arao T, Yajima N et al. Identification of expressed genes characterizing long-term survival in malignant glioma patients. Oncogene 2006; 25: 59946002.
  • 12
    Petalidis LP, Oulas A, Backlund M et al. Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data. Mol Cancer Ther 2008; 7: 101324.
  • 13
    Verhaak RGW, Hoadley KA, Purdom E et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010; 17: 98110.
  • 14
    Kawaguchi A, Yajima N, Komohara Y et al. Identification and validation of a gene expression signature that predicts outcome in malignant glioma patients. Int J Oncol 2012; 40: 72130.
  • 15
    Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 4028.
  • 16
    Nakasu S, Fukami T, Baba K, Matsuda M. Immunohistochemical study for O6-methylguanine-DNA methyltransferase in the non-neoplastic and neoplastic components of gliomas. J Neurooncol 2004; 70: 33340.
  • 17
    Balss J, Meyer J, Mueller W et al. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 2008; 116: 597602.
  • 18
    R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2011. [Cited 10 Dec 2012.] Available from URL: http://www.R-project.org.
  • 19
    Gentleman R, Carey V, Bates D et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5: R80.
  • 20
    Ishwaran H, Kogalur UB, Gorodeski EZ et al. High-dimensional variable selection for survival data. J Amer Stat Assoc 2010; 105: 20517.
  • 21
    Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3: 325.
  • 22
    Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455: 10618.
  • 23
    LeBlanc M, Crowley J. Relative risk trees for censored survival data. Biometrics 1992; 48: 41125.
  • 24
    Cordell HJ. Detecting gene–gene interactions that underlie human diseases. Nat Rev Genet 2009; 10: 392404.
  • 25
    Kawaguchi A, Iwadate Y, Komohara Y et al. Gene expression signature-based prognostic risk score in patients with primary central nervous system lymphoma. Clin Cancer Res 2012; 18: 567281.